RT @CD_AACR: #ICYMI: Targeting p300/CBP in lethal prostate cancer. https://t.co/fCL8uil9Xf. @AdamSharpMedOnc @Nb10Nigel @NeilPegg1 @ICR_Lon…
RT @CD_AACR: #ICYMI: Targeting p300/CBP in lethal prostate cancer. https://t.co/fCL8uil9Xf. @AdamSharpMedOnc @Nb10Nigel @NeilPegg1 @ICR_Lon…
#ICYMI: Targeting p300/CBP in lethal prostate cancer. https://t.co/fCL8uil9Xf. @AdamSharpMedOnc @Nb10Nigel @NeilPegg1 @ICR_London. #ProstateCancerAwarenessMonth https://t.co/TqKy8hvdSc
RT @CD_AACR: From the May issue: Targeting p300/CBP axis in lethal #prostatecancer by Johann S. de Bono. @AdamSharpMedOnc @Nb10Nigel @Neil…
RT @CD_AACR: From the May issue: Targeting p300/CBP axis in lethal #prostatecancer by Johann S. de Bono. @AdamSharpMedOnc @Nb10Nigel @Neil…
RT @CD_AACR: From the May issue: Targeting p300/CBP axis in lethal #prostatecancer by Johann S. de Bono. @AdamSharpMedOnc @Nb10Nigel @Neil…
Characterises @CellCentric CCS1477, first in class small molecule p300/CBP inhibitor...
RT @CD_AACR: From the May issue: Targeting p300/CBP axis in lethal #prostatecancer by Johann S. de Bono. @AdamSharpMedOnc @Nb10Nigel @Neil…
RT @CD_AACR: From the May issue: Targeting p300/CBP axis in lethal #prostatecancer by Johann S. de Bono. @AdamSharpMedOnc @Nb10Nigel @Neil…
RT @CD_AACR: From the May issue: Targeting p300/CBP axis in lethal #prostatecancer by Johann S. de Bono. @AdamSharpMedOnc @Nb10Nigel @Neil…
From the May issue: Targeting p300/CBP axis in lethal #prostatecancer by Johann S. de Bono. @AdamSharpMedOnc @Nb10Nigel @NeilPegg1 @royalmarsdenNHS @ICR_London https://t.co/W3yNYJjlcu https://t.co/taNXotuGyo
RT @ChesterfordRP: #ParkNews Congratulations to @CellCentric on the publication in Cancer Discovery of a research article on targeting the…
#ParkNews Congratulations to @CellCentric on the publication in Cancer Discovery of a research article on targeting the p300/CBP axis in lethal prostate cancer with first-in-class p300/CBP inhibitor CCS1477. Find it here: https://t.co/0ECPVzP0nT https://t.
RT @CellCentric: CCS1477 pivotal publication now in final form and in print in Cancer Discovery. First-in-class p300/CBP inhibitor. See: h…
RT @CellCentric: CCS1477 pivotal publication now in final form and in print in Cancer Discovery. First-in-class p300/CBP inhibitor. See: h…
RT @CellCentric: CCS1477 pivotal publication now in final form and in print in Cancer Discovery. First-in-class p300/CBP inhibitor. See: h…
RT @CellCentric: CCS1477 pivotal publication now in final form and in print in Cancer Discovery. First-in-class p300/CBP inhibitor. See: h…
CCS1477 pivotal publication now in final form and in print in Cancer Discovery. First-in-class p300/CBP inhibitor. See: https://t.co/YcskruVUWZ https://t.co/bNeLXdGfDl
RT @OncoAlert: Friends at #AACR21 While you check out the GREAT science, check out our @OncoAlert 🚨@CD_AACR academic Recap Like this one!!…
RT @OncoAlert: Friends at #AACR21 While you check out the GREAT science, check out our @OncoAlert 🚨@CD_AACR academic Recap Like this one!!…
RT @OncoAlert: Friends at #AACR21 While you check out the GREAT science, check out our @OncoAlert 🚨@CD_AACR academic Recap Like this one!!…
RT @OncoAlert: Friends at #AACR21 While you check out the GREAT science, check out our @OncoAlert 🚨@CD_AACR academic Recap Like this one!!…
Friends at #AACR21 While you check out the GREAT science, check out our @OncoAlert 🚨@CD_AACR academic Recap Like this one!! "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London & @royalmarsdenNHS Discussed by @OncoAlert
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @Martin_AngelMD: Great summary of #pcsm by @neerajaiims! https://t.co/BYFKKp6X66
RT @Martin_AngelMD: Great summary of #pcsm by @neerajaiims! https://t.co/BYFKKp6X66
RT @Martin_AngelMD: Great summary of #pcsm by @neerajaiims!
Great summary of #pcsm by @neerajaiims!
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
RT @PGrivasMDPhD: @neerajaiims @OncoAlert
RT @TiansterZhang: Great paper discussed by @neerajaiims to think through molecular targets for aggressive #prostatecancer. Excellent work…
RT @TiansterZhang: Great paper discussed by @neerajaiims to think through molecular targets for aggressive #prostatecancer. Excellent work…
RT @ElizSMcKenna: A new @OncoAlert-@CD_AACR Academic Recap is now live! This one discusses recent work by @AdamSharpMedOnc @Nb10Nigel @Nei…
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
RT @TiansterZhang: Great paper discussed by @neerajaiims to think through molecular targets for aggressive #prostatecancer. Excellent work…
RT @ElizSMcKenna: A new @OncoAlert-@CD_AACR Academic Recap is now live! This one discusses recent work by @AdamSharpMedOnc @Nb10Nigel @Nei…
RT @ElizSMcKenna: A new @OncoAlert-@CD_AACR Academic Recap is now live! This one discusses recent work by @AdamSharpMedOnc @Nb10Nigel @Nei…
RT @TiansterZhang: Great paper discussed by @neerajaiims to think through molecular targets for aggressive #prostatecancer. Excellent work…
RT @TiansterZhang: Great paper discussed by @neerajaiims to think through molecular targets for aggressive #prostatecancer. Excellent work…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @PGrivasMDPhD: @OncoAlert
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
@neerajaiims @OncoAlert
@OncoAlert
RT @TiansterZhang: Great paper discussed by @neerajaiims to think through molecular targets for aggressive #prostatecancer. Excellent work…
Great paper discussed by @neerajaiims to think through molecular targets for aggressive #prostatecancer. Excellent work from @AdamSharpMedOnc and team!!
RT @ElizSMcKenna: A new @OncoAlert-@CD_AACR Academic Recap is now live! This one discusses recent work by @AdamSharpMedOnc @Nb10Nigel @Nei…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
No Se pierdan este Academic Recap de @OncoAlert & @CD_AACR con nuestro colega @neerajaiims !!
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @ElizSMcKenna: A new @OncoAlert-@CD_AACR Academic Recap is now live! This one discusses recent work by @AdamSharpMedOnc @Nb10Nigel @Nei…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @OncoAlert: The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London &…
RT @ElizSMcKenna: A new @OncoAlert-@CD_AACR Academic Recap is now live! This one discusses recent work by @AdamSharpMedOnc @Nb10Nigel @Nei…
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
A new @OncoAlert-@CD_AACR Academic Recap is now live! This one discusses recent work by @AdamSharpMedOnc @Nb10Nigel @NeilPegg1 Johann de Bono and colleagues at @royalmarsdenNHS @ICR_London #prostatecancer
RT @weoncologists: The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing…
The 2⃣nd @OncoAlert 🚨 @CD_AACR Academic Recap is out with none other than our AMAZING Colleague @neerajaiims discussing: "Targeting p300/CBP axis in lethal #ProstateCancer" Paper found for free for 1 week courtesy of CANCER DISCOVERY!!! https://t.co/q5
The @OncoAlert 🚨 @CD_AACR Academic Recap "Targeting p300/CBP axis in lethal #ProstateCancer" by colleagues at @ICR_London & @royalmarsdenNHS Discussed by @OncoAlert Colleague &GU #Cancer Faculty @neerajaiims 👨⚕️🇺🇸 Paper available for FREE for1
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @ElizSMcKenna: Coming later this week!!
RT @weoncologists: Coming in 2⃣Days..... The @OncoAlert 🚨 @CD_AACR Academic Recap Paper will be available for FREE for 1⃣ week upon rele…
RT @weoncologists: Coming in 2⃣Days..... The @OncoAlert 🚨 @CD_AACR Academic Recap Paper will be available for FREE for 1⃣ week upon rele…
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @weoncologists: Coming in 2⃣Days..... The @OncoAlert 🚨 @CD_AACR Academic Recap Paper will be available for FREE for 1⃣ week upon rele…
Coming in 2⃣Days..... The @OncoAlert 🚨 @CD_AACR Academic Recap Paper will be available for FREE for 1⃣ week upon release of the Recap courtesy of CANCER DISCOVERY
Targeting p300/CBP axis in lethal prostate cancer - Cancer Discovery https://t.co/LbaSqpconn
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
@neerajaiims @OncoAlert
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @ElizSMcKenna: Coming later this week!! https://t.co/gvyp8QfJ3R
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
Coming later this week!!
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…
RT @OncoAlert: The 2⃣nd paper of the @OncoAlert 🚨 @CD_AACR Academic Recap has been chosen On March 3⃣1⃣st Our OncoAlert🌐Colleague @neera…